Sarina Schwarz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Health Insurance

Loop Mediated Isothermal Amplification

Colorectal Cancer Screening

Top Venues

Clinical and translational gastroenterology

Future oncology (London, England)

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Sarina Schwarz, Wiebke Schafer, Dirk Horenkamp-Sonntag, Judith Liebentraut, Ulrike Haug
Correction to: Follow-Up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years. Clinical and translational gastroenterology 15 (2) (2024)
Sarina Schwarz, Wiebke Schafer, Dirk Horenkamp-Sonntag, Judith Liebentraut, Ulrike Haug
Correction to: Follow-Up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years. Clinical and translational gastroenterology 15 (2) (2024)
Sarina Schwarz, Wiebke Schafer, Dirk Horenkamp-Sonntag, Judith Liebentraut, Ulrike Haug
Correction to: Follow-Up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years. Clinical and translational gastroenterology 15 (2) (2024)
Sarina Schwarz, Wiebke Schafer, Dirk Horenkamp-Sonntag, Judith Liebentraut, Ulrike Haug
Correction to: Follow-Up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years. Clinical and translational gastroenterology 15 (2) (2024)
Sarina Schwarz, Michel Hornschuch, Christian Pox, Ulrike Haug
Polyp detection rate and cumulative incidence of post-colonoscopy colorectal cancer in Germany. International journal of cancer (2022)
Sarina Schwarz, Michel Hornschuch, Dr Christian Pox, Dr Ulrike Haug
COLORECTAL CANCER AFTER SCREENING COLONOSCOPY: 10-YEAR INCIDENCE BY SITE AND DETECTION RATE AT FIRST REPEAT COLONOSCOPY. Clinical and translational gastroenterology (2022)
Sarina Schwarz, Katja A Oppelt, Miriam Heinig, Ulrike Haug
Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinib. Future oncology (London, England) 17 (18) (2021)